No black box warning on record for Vabysmo

As of the latest FDA labeling reviewed, Vabysmo (FARICIMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Vabysmo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Endophthalmitis and retinal detachments may occur following intravitreal injections. Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay, to permit prompt and appropriate management. ( 5.1 ) Increases in intraocular pressure have been seen within 60 minutes of an intravitreal injection. ( 5.2 ) There is a

No black box warning on record for Vabysmo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Endophthalmitis and retinal detachments may occur following intravitreal injections. Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay, to permit prompt and appropriate management. ( 5.1 ) Increases in intraocular pressure have been seen within 60 minutes of an intravitreal injection. ( 5.2 ) There is a

Vabysmo Black Box Warning

No black box warning on record for Vabysmo

Other warnings & precautions

Vabysmo Black Box Warning

No black box warning on record for Vabysmo

Other warnings & precautions